Linagliptin Waalidka Nucleus Dhexdhexaadiyaha CAS 853029-57-9 Nadiifnimada ≥99.0% Warshada
Soo saaraha Linagliptin iyo Dhexdhexaadiyeyaasha la xidhiidha:
Linagliptin CAS 668270-12-0
Dhexdhexaadiyaha Nucleus Waalidka ee Linagliptin CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino) piperidine CAS 309956-78-3
(R)-(-)-3-Aminopperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0
Magaca Kiimikada | 8-Bromo-7-laakin-2-ynyl-3-methyl-1- (4-methyl-quinazolin-2-ylmethyl) -3,7-dihydro-purine-2,6-dione |
La mid ah | Linagliptin Nucleus Waalidka;Dhexdhexaadiyaha Linagliptin F |
Lambarka CAS | 853029-57-9 |
Lambarka CAT | RF-PI502 |
Heerka Saamiyada | Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan |
Qaanuunka molecular | C20H17BrN6O2 |
Miisaanka Molecular | 453.29 |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Caddaan ilaa qafiif ah budada jaalaha ah |
Aqoonsiga | IR/HPLC |
daahirnimo | ≥99.0% |
Biyaha (KF) | ≤1.0% |
Hadhaaga dabka | ≤0.50% |
Wadarta wasakhda | ≤1.0% |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyaha Linagliptin (CAS: 668270-12-0) |
Xidhmada: Dhalo, bacda bireed ee aluminium, 25kg / Durbaan kartoonada, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka.
8-Bromo-7-laakiin-2-ynyl-3-methyl-1- (4-methyl-quinazolin-2-ylmethyl) -3,7-dihydro-purine-2,6-dione (CAS: 853029-57- 9) waa xudunta waalidka ee Linagliptin (CAS: 668270-12-0).Linagliptin (magacyada ganacsiga Tradjenta iyo Trajetna) waa horjooge dipeptidyl peptidase-4 (DPP-4) kaas oo ay ansixisay US FDA bishii Maajo 2011 daawaynta nooca 2 ee sonkorowga oo ay weheliso cunto iyo jimicsi.Linagliptin (BI-1356) ayaa lagu tilmaamay inuu yahay mid awood badan oo la xushay, heerka gaabinaya iyo xannibaadaha muddada dheer ee DPP-4.Linagliptin wuxuu ka dhashay dadaallada hagaajinta ee xanthine-based DPP-4 inhibitors oo leh rasaasta bilowga ah ee lagu aqoonsaday ololaha HTS.